◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
MRSN: Mersana Therapeutics Inc Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,149.56 |
| Enterprise Value ($M) | 933.28 |
| Book Value ($M) | 228.09 |
| Book Value / Share | 3.30 |
| Price / Book | 5.19 |
| NCAV ($M) | 213.27 |
| NCAV / Share | 3.09 |
| Price / NCAV | 5.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.38 |
| Return on Assets (ROA) | -0.82 |
| Return on Equity (ROE) | -1.12 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | 8.62 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 258.58 |
| Assets | 273.40 |
| Liabilities | 45.31 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | -88.05 |
| Earnings Per Share Basic And Diluted | -1.43 |
| Earnings Per Share Diluted | -1.43 |
| Earnings Per Share Basic | -1.43 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -74.70 |
| Cash from Investing | 37.03 |
| Cash from Financing | 37.03 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Pfizer Inc | 0.00 | -100.00 | |
| 13G | Avoro Capital Advisors LLC | 9.90 | ||
| 13G/A | Biotechnology Value Fund L P | 0.00 | -100.00 | |
| 13G | Wellington Management Group Llp | 6.79 | 381.23 | |
| 13G/A | BlackRock Inc. | 11.70 | 0.00 | |
| 13G | Sarissa Capital Management LP | 5.50 | 0.53 | |
| 13D/A | Bain Capital Life Sciences Fund II, L.P. | 4.80 | 7.26 | |
| 13D/A | New Enterprise Associates 14, L.P. | |||
| 13G/A | ArrowMark Colorado Holdings LLC | 0.00 | -100.00 | |
| 13G | Venrock Healthcare Capital Partners II, L.P. | 5.20 | 0.00 | |
| 13G/A | Rock Springs Capital Management LP | 4.31 | -24.63 | |
| 13G/A | Fmr Llc | 3.88 | ||
| 13G | Rho Ventures V, L.P. | 5.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Annual Report – 10-K | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 44,603 | 461,000 | 9.68 | |
| 65,060 | 712,748 | 9.13 | |
| 84,218 | 681,338 | 12.36 | |
| 99,476 | 401,518 | 24.77 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MRKR – Marker Therapeutics Inc | MRNA – Moderna Inc |
| MRNS – Marinus Pharmaceuticals Inc | MRTX – Mirati Therapeutics Inc |
| MRUS – Merus N.V. |
Financial data and stock pages provided by
Fintel.io
2018/07/06
